Ultra-low-dose Whole-body CT Using AI-based CT Reconstruction in Patients With Multiple Myeloma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-06

Study Completion Date

2023-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective study aims to perform intra-individual comparison of the image quality between ultra-low-dose whole-body CT with deep learning reconstruction and conventional low-dose whole-body CT with iterative reconstruction in patients with suspected multiple myeloma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Automated Segmentation and Volumetry for Meningioma Using Deep Learning

NCT05093751

Meningioma Artificial Intelligence

COMPLETED

Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning

NCT05624736

Astrocytoma Glioblastoma Multiforme Oligodendroglioma

UNKNOWN

AI-assisted Diagnosis of Malignant Brain Tumors

NCT07198256

Gliomas Brain Metastases, Adult Lymphoma +1 more

RECRUITING

Multi-parametric Imaging in Personalized Radiotherapy

NCT05888064

Skull Base Chordoma

RECRUITING

PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor

NCT02071017

Brain Tumor

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Myeloma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multiple myeloma

Patients with suspicion of multiple myeloma and scheduled for CT

noncontrast-enhanced whole-body CT

Intervention Type DIAGNOSTIC_TEST

noncontrast-enhanced low-dose whole-body CT using dual-source CT scanner using A-tube (75% radiation) and B-tube (25% radiation).

* conventional low-dose CT data (A +B tubes, 100% dose) are reconstructed with iterative reconstruction
* ultra-low dose CT data (B-tube only, 25% dose) are reconstructed with deep learning commercially available software.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

noncontrast-enhanced whole-body CT

noncontrast-enhanced low-dose whole-body CT using dual-source CT scanner using A-tube (75% radiation) and B-tube (25% radiation).

* conventional low-dose CT data (A +B tubes, 100% dose) are reconstructed with iterative reconstruction
* ultra-low dose CT data (B-tube only, 25% dose) are reconstructed with deep learning commercially available software.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* signed informed consent
* patients with suspected multiple myeloma and scheduled for noncontrast-enhanced low-dose whole-body CT
* patients who have no previous history of chemotherapy for multiple myeloma